Christopher Rovaldi
Insider Reports History
- Location
- Cambridge, MA
- Signature
- /s/ Keith Regnante, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Christopher Rovaldi:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Keros Therapeutics, Inc. | Chief Operating Officer | Common Stock | 60,000 | $2,640,600 | $44.01 | 18 Feb 2025 | Direct |
Insider Reports Filed by Christopher Rovaldi
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KROS | Keros Therapeutics, Inc. | 18 Feb 2025 | 1 | $0 | 4 | Chief Operating Officer | 19 Feb 2025, 16:15 |
| KROS | Keros Therapeutics, Inc. | 13 Feb 2024 | 1 | $0 | 4 | CHIEF OPERATING OFFICER | 15 Feb 2024, 20:38 |
| KROS | Keros Therapeutics, Inc. | 16 Feb 2023 | 1 | $0 | 4 | Chief Operating Officer | 17 Feb 2023, 15:19 |
| KROS | Keros Therapeutics, Inc. | 06 Apr 2022 | 3 | -$84,672 | 4 | Chief Operating Officer | 08 Apr 2022, 16:21 |
| KROS | Keros Therapeutics, Inc. | 01 Apr 2022 | 7 | -$35,851 | 4 | Chief Operating Officer | 05 Apr 2022, 16:31 |
| KROS | Keros Therapeutics, Inc. | 01 Feb 2022 | 1 | $0 | 4 | Chief Operating Officer | 03 Feb 2022, 15:45 |
| KROS | Keros Therapeutics, Inc. | 01 Feb 2022 | 0 | $0 | 3 | Chief Operating Officer | 03 Feb 2022, 15:37 |